Compelling pre clinical results with compete eradication of all tumours in mice for 7 cancer lines and no reoccurrence
Car T was developed by the University of Pennsylvania. They are generally recognised as the pioneers of Car-T therapy
Only 3 companies are developing therapies targeting CDH17, and we are the ONLY company with Car T in the clinic (soon) and a NK CDH17 in preclinical trial
Gastric, colorectal and NED cancers represent some of the largest oncology segments with single digit to low teen 5 year survival rates - ie huge markets with unmet needs
There are over 5+ million gastric cancer diagnoses annually
CDH17 is a novel antigen that has only recently been attracting attention as a potential cancer target. CD19 and BCMA have been the main antigens targeted by by biotech companies for blood cancers over the last few years.
Paul Hopper was quoted a few years ago as saying that licensing CDH17 Car T from the University of Pennsylvania was one of the best deals he has ever inked in the biotech space.
CDH 17 Car T featured on the cover of Nature Oncology vaccine so it has been rigorously reviewed and independently verified
If the CDH17 Car T works then the NK therapy will also attract a huge valuation
CDH17 Car T is targeting solid tumours and is poised to be the first Car T to demonstrate amazing efficacy like the CD19 B cell blood cancers
Big pharma will be watching the progress on this trial very closely.
So watch this space!!
- Forums
- ASX - By Stock
- CHM
- CDH17 Car T therapy has blockbuster potential
CDH17 Car T therapy has blockbuster potential
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $17.52M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $1.057K | 55.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 242221 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1104755 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 242221 | 0.018 |
5 | 1549367 | 0.017 |
10 | 2820994 | 0.016 |
9 | 4479999 | 0.015 |
5 | 2331428 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1104755 | 4 |
0.021 | 488333 | 3 |
0.022 | 200000 | 1 |
0.023 | 150000 | 1 |
0.024 | 200000 | 1 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |